Lung Cancer Patient Story: Multidisciplinary Expertise Backed by Cutting-edge Treatment
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General Brigham.
The Center for Thoracic Cancers offers patients and families access to one of New England's most experienced programs for lung cancer.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all lung cancer cases.
The pace of growth for this disease is highly variable, but in general, it tends to grow at a slower rate than small cell lung cancer (SCLC). However, like SCLC, it can spread to other parts of the body.
Non-small cell lung cancer is more prevalent in people who have smoked, but other factors can cause the disease to develop.
At the Mass General Brigham Cancer Institute, you receive care from an experienced team dedicated to diagnosing and treating lung cancer. Together, they develop a personalized treatment plan based on the type and stage of cancer, genetic and molecular findings, and your overall health and goals.
There are three main types of non-small cell lung cancer. Each has distinct characteristics and growth patterns.
Because non-small cell lung cancer can spread to other parts of the body, early diagnosis may help prevent or slow its progression.
Common NSCLC symptoms include:
Other non-small cell lung cancer signs and symptoms to watch for include:
If you experience any of these symptoms, particularly if you have smoked, see your health care provider for an evaluation and testing.
Although smoking is responsible for most non-small cell lung cancer cases, there are other causes of NSCLC. You may be at risk of developing non-small cell lung cancer if you regularly inhale secondhand smoke or are exposed to workplace carcinogens or toxins like asbestos or radiation.
Taking preventive measures can help lower the risk of developing non-small cell lung cancer. To reduce your chances of getting NSCLC, follow these preemptive steps:
The first steps typically involve a consultation and physical exam. Your health care provider will go over your medical and family history and determine potential risk factors, including whether you have smoked or if your line of work exposes you to toxins or carcinogens.
Your physician may then order diagnostic testing based on the results of your exam and consultation. These procedures may include:
If you’ve been diagnosed with non-small cell lung cancer, your health care provider will work with you on a treatment plan.
Treatment for NSCLC may involve a multidisciplinary team of health care experts. Your care team will work together to develop an individualized treatment plan based on factors such as:
Local therapies are cancer treatments that target a specific part of the body, such as the lung, to treat cancer. Examples of local therapy for lung cancer are:
Surgery may be a recommended course of action in non-small cell lung cancer cases where the tumor is confined to one lung and hasn’t metastasized to lymph nodes or other organs. Surgical options may vary depending on the size and location of the tumor:
This form of non-small cell lung cancer therapy uses high-energy to kill or shrink cancer cells. Radiation therapy can be beneficial for early-stage or advanced NSCLC and is non-invasive. Lung cancer specialists often use this form of therapy in conjunction with chemotherapy.
The three main types of radiation therapy used to treat lung cancer are:
This procedure uses extreme temperatures to destroy cancer cells. Heat techniques include radiofrequency and microwave ablation. Cryoablation uses liquid nitrogen or argon gas to freeze tumor cells. Explore Mass General’s thermal ablation programs.
Systemic therapy is a drug treatment that can affect the entire body. Examples of systemic therapies for lung cancer are:
Chemotherapy involves the use of medicine administered orally or intravenously. The medication travels through the bloodstream to kill cancer cells or keep them from growing and spreading. Chemotherapy is often used as the primary treatment for more advanced NSCLC or in combination with surgery or radiation therapy.
Learn more about chemotherapy and lung cancer.
Immunotherapy uses immune checkpoint inhibitors to work with your body’s immune system. These inhibitors stimulate the immune system to locate and attack cancer cells.
Learn more about immunotherapy for lung cancer.
This therapy can help improve outcomes and reduce side effects compared to chemotherapy drugs. Targeted therapy may be used before surgery to make removing a tumor easier. It can also fight any remaining cancer cells after surgery.
Learn more about clinical trials for targeted drug therapy.
The multidisciplinary treatment team for non-small cell lung cancer consists of lung specialists who will provide care tailored to your specific needs.
Key members of your team may include:
Non-small cell lung cancer can vary from person to person. Your oncologist will be able to answer any questions you may have about your prognosis and the best treatment options for you.
The rate at which NSCLC progresses varies from person to person. Some tumors grow slowly, while others spread rapidly. The type of cancer and how early it gets diagnosed can factor into its progression. Your overall health, age, and immune system can also impact the rate at which the cancer develops.
Early detection of NSCLC is critical because the disease can spread to other parts of the body over time. If you receive an NSCLC diagnosis, there are various treatment options available depending on the type and stage of the cancer and your overall health.
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General Brigham.
Contact us to make an appointment or to learn more about our programs.